Aevi Genomic Medicine to Present at the JMP Securities Life Sciences Conference
Aevi Genomic Medicine Announces Plans to Initiate Phase 2 Clinical Trial to Confirm Genetic Responders to AEVI-001 and First Quarter 2017 Operating Results
Aevi Genomic Medicine to Host Conference Call to Announce First Quarter and Discuss Recent Business Updates
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news